Top

Published in:

01-08-2009 | Letter to the Editor

M694V mutation may have a role in susceptibility to ankylosing spondylitis

Authors: Servet Akar, Merih Birlik, Ismail Sarı, Fatos Onen, Nurullah Akkoc

Published in: Rheumatology International | Issue 10/2009

Excerpt

Familial Mediterranean fever (FMF) is an autosomal recessive disease, characterized by recurrent attacks of fever and serositis. Musculoskeletal involvement mostly in the form of arthritis is a common manifestation of FMF [1]. Moreover, an increased frequency of spondyloarthritis (SpA) including ankylosing spondylitis (AS) has been suggested by several case reports and two large observational studies [1, 2]. …

FMF Turkish study group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11. doi:10.1097/01.md.0000152370.84628.0c CrossRef

Langevitz P, Livneh A, Zemer D, Shemer J, Mordechai P (1997) Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 27(2):67–72. doi:10.1016/S0049-0172(97)80007-8 PubMedCrossRef

French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31. doi:10.1038/ng0997-25 CrossRef

International FMF Consortium (1997) Ancient missense mutations in a new member of RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807. doi:10.1016/S0092-8674(00)80539-5 CrossRef

Canete JD, Arostegui JI, Queiro R, Gratacos J, Hernandez MV, Larrosa M et al (2007) An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis Rheum 56(8):2784–2788. doi:10.1002/art.22755 PubMedCrossRef

Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R et al (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30:2014–2018PubMed

Tunca M, Akar S, Hawkins PN, Booth SE, Sengul B, Yavuzsen TU et al (2002) The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur J Hum Genet 10:786–789. doi:10.1038/sj.ejhg.5200900 PubMedCrossRef

Balaban B, Yasar E, Ozgul A, Dincer K, Kalyon TA (2005) Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis. Rheumatol Int 25(8):641–644. doi:10.1007/s00296-004-0578-2 PubMedCrossRef

Incel NA, Saracoglu M, Erdem HR (2003) Seronegative spondyloarthropathy of familial Mediterranean fever. Rheumatol Int 23(1):41–43PubMed

10.

van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368. doi:10.1002/art.1780270401 PubMedCrossRef

11.

Stehlik C, Lee SH, Dorfleutner A, Stassinopoulos A, Sagara J, Reed JC (2003) Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol 171(11):6154–6163PubMed

12.

Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP et al (2003) Targeted distruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 11(3):591–604. doi:10.1016/S1097-2765(03)00056-X PubMedCrossRef

13.

Flato B, Smerdel A, Johnston V, Lien G, Dale K, Vinje O et al (2002) The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis. Arthritis Rheum 46(4):986–994. doi:10.1002/art.10146 PubMedCrossRef

14.

Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S et al (2001) Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 102(3):272–276. doi:10.1002/ajmg.1438 PubMedCrossRef

15.

Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N et al (2001) Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9(7):553–555. doi:10.1038/sj.ejhg.5200674 PubMedCrossRef

16.

Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O et al (2008) Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 35(2):305–309PubMed

17.

Cinar M, Dinc A, Simsek I, Erdem H, Koc B, Pay S et al (2008) The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int 29(1):37–42. doi:10.1007/s00296-008-0637-1 PubMedCrossRef

Title: M694V mutation may have a role in susceptibility to ankylosing spondylitis
Authors: Servet Akar
Merih Birlik
Ismail Sarı
Fatos Onen
Nurullah Akkoc
Publication date: 01-08-2009
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 10/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-009-0839-1

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

M694V mutation may have a role in susceptibility to ankylosing spondylitis

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2009

Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature

A systematic medline analysis of therapeutic approaches in ankylosing spondylitis

Prevalence, pattern and determinants of radiographic hand osteoarthritis in Turkmen community-based sample

Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-α

Cogan’s syndrome: present and future directions

Comparing fibromyalgia patients from primary care and rheumatology settings: clinical and psychosocial features

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page